Northern Trust’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $16.3M | Buy |
|
|||||
|
2025
Q2 | $14.7M | Buy |
|
|||||
|
2025
Q1 | $12.7M | Buy |
|
|||||
|
2024
Q4 | $16.2M | Buy |
|
|||||
|
2024
Q3 | $13.3M | Buy |
|
|||||
|
2024
Q2 | $9.86M | Buy |
|
|||||
|
2024
Q1 | $12.8M | Sell |
|
|||||
|
2023
Q4 | $12.8M | Sell |
|
|||||
|
2023
Q3 | $10M | Buy |
|
|||||
|
2023
Q2 | $9.35M | Buy |
|
|||||
|
2023
Q1 | $7.71M | Sell |
|
|||||
|
2022
Q4 | $8.94M | Buy |
|
|||||
|
2022
Q3 | $12.1M | Buy |
|
|||||
|
2022
Q2 | $7.99M | Buy |
|
|||||
|
2022
Q1 | $6.15M | Sell |
|
|||||
|
2021
Q4 | $15.2M | Buy |
|
|||||
|
2021
Q3 | $5.77M | Buy |
|
|||||
|
2021
Q2 | $8.85M | Buy |
|